Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023

SELL
$36.71 - $44.15 $215,120 - $258,719
-5,860 Reduced 2.61%
218,251 $9.08 Million
Q1 2023

Apr 19, 2023

SELL
$36.81 - $48.12 $109,841 - $143,590
-2,984 Reduced 1.31%
224,111 $9.26 Million
Q4 2022

Feb 02, 2023

SELL
$35.68 - $44.71 $335,106 - $419,916
-9,392 Reduced 3.97%
227,095 $9.37 Million
Q3 2022

Oct 24, 2022

SELL
$42.51 - $54.02 $196,736 - $250,004
-4,628 Reduced 1.92%
236,487 $10.4 Million
Q2 2022

Jul 19, 2022

BUY
$46.84 - $59.75 $3.21 Million - $4.09 Million
68,466 Added 39.66%
241,115 $11.9 Million
Q1 2022

May 09, 2022

BUY
$48.09 - $57.79 $8.3 Million - $9.98 Million
172,649 New
172,649 $9.79 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Leeward Investments, LLC Ma Portfolio

Follow Leeward Investments, LLC Ma and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leeward Investments, LLC Ma, based on Form 13F filings with the SEC.

News

Stay updated on Leeward Investments, LLC Ma with notifications on news.